Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125796122 | 12579612 | 2 | F | 20160513 | 20160830 | 20160721 | 20160831 | EXP | GB-MHRA-MIDB-5B49B96D-5342-4953-BAA2-958D70213175 | GB-FRI-1000085989 | FOREST | 71.00 | YR | M | Y | 0.00000 | 20160831 | OT | DK | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125796122 | 12579612 | 1 | PS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | 40 MG ONCE DAILY | U | 20822 | 40 | MG | QD | ||||||
| 125796122 | 12579612 | 2 | I | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | 500 MG TWICE DAILY | Y | 0 | 500 | MG | BID | ||||||
| 125796122 | 12579612 | 3 | I | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Y | 0 | |||||||||||
| 125796122 | 12579612 | 4 | I | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Y | 0 | |||||||||||
| 125796122 | 12579612 | 5 | I | NAPROXEN. | NAPROXEN | 1 | Oral | 500 MG TWICE DAILY | U | 0 | 500 | MG | BID | ||||||
| 125796122 | 12579612 | 6 | C | AVAMYS | FLUTICASONE FUROATE | 1 | Nasal | 55 MICROGRAMS ONCE DAILY | 0 | 55 | UG | QD | |||||||
| 125796122 | 12579612 | 7 | C | CETRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 10 MG ONCE DAILY | 0 | 10 | MG | QD | |||||||
| 125796122 | 12579612 | 8 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | Oral | 200 MG THREE TIMES DAILY | 0 | 200 | MG | TID | |||||||
| 125796122 | 12579612 | 9 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | Topical | 0 | |||||||||||
| 125796122 | 12579612 | 10 | C | LAXIDO | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | Oral | 13.7 G AS NECESSARY | 0 | ||||||||||
| 125796122 | 12579612 | 11 | C | LOSARTAN. | LOSARTAN | 1 | Unknown | 50 MG ONCE DAILY | 0 | 50 | MG | QD | |||||||
| 125796122 | 12579612 | 12 | C | MICONAZOLE. | MICONAZOLE | 1 | Topical | 0 | |||||||||||
| 125796122 | 12579612 | 13 | C | NASEPTIN | CHLORHEXIDINE HYDROCHLORIDENEOMYCIN SULFATE | 1 | Topical | 0 | |||||||||||
| 125796122 | 12579612 | 14 | C | NEFOPAM | NEFOPAM | 1 | Oral | 30 MG THREE TIMES DAILY | 0 | 30 | MG | TID | |||||||
| 125796122 | 12579612 | 15 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG ONCE DAILY | 0 | 20 | MG | QD | |||||||
| 125796122 | 12579612 | 16 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | AS NECESSARY | 0 | ||||||||||
| 125796122 | 12579612 | 17 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 20 MG ONCE DAILY | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125796122 | 12579612 | 1 | Product used for unknown indication |
| 125796122 | 12579612 | 2 | Ear infection |
| 125796122 | 12579612 | 3 | Rhinitis |
| 125796122 | 12579612 | 4 | Pharyngitis |
| 125796122 | 12579612 | 5 | Product used for unknown indication |
| 125796122 | 12579612 | 6 | Product used for unknown indication |
| 125796122 | 12579612 | 7 | Product used for unknown indication |
| 125796122 | 12579612 | 8 | Product used for unknown indication |
| 125796122 | 12579612 | 9 | Product used for unknown indication |
| 125796122 | 12579612 | 10 | Product used for unknown indication |
| 125796122 | 12579612 | 11 | Product used for unknown indication |
| 125796122 | 12579612 | 12 | Product used for unknown indication |
| 125796122 | 12579612 | 13 | Product used for unknown indication |
| 125796122 | 12579612 | 14 | Product used for unknown indication |
| 125796122 | 12579612 | 15 | Product used for unknown indication |
| 125796122 | 12579612 | 16 | Product used for unknown indication |
| 125796122 | 12579612 | 17 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125796122 | 12579612 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125796122 | 12579612 | Drug interaction | |
| 125796122 | 12579612 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125796122 | 12579612 | 2 | 20160506 | 20160513 | 0 | |
| 125796122 | 12579612 | 17 | 20160506 | 20160511 | 0 |